Business
Currency:USD
2023/FY
Stock NameRevenueRatio
Developing, manufacturing and marketing off-patented generic and biosimilar medicines9.98B100.00%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
Other6.43B64.41%
United States1.62B16.20%
Germany1.24B12.43%
Switzerland363M3.64%
Sales to former parent302M3.03%
Other revenues30M0.30%
View all